Cargando…

Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study

BACKGROUND: Endogenous Cushing’s syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. So far, most studies focussed on distinct disease entities rather than the integrity of the CV system. We here describe the design of the Cardiovascular Status in Endogenous Cortisol Exce...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrlich, Kristina, Morbach, Caroline, Reiter, Theresa, Heuschmann, Peter Ulrich, Hannemann, Anke, Fassnacht, Martin, Störk, Stefan, Hahner, Stefanie, Deutschbein, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791745/
https://www.ncbi.nlm.nih.gov/pubmed/33419423
http://dx.doi.org/10.1186/s12902-020-00665-7
_version_ 1783633657388335104
author Ehrlich, Kristina
Morbach, Caroline
Reiter, Theresa
Heuschmann, Peter Ulrich
Hannemann, Anke
Fassnacht, Martin
Störk, Stefan
Hahner, Stefanie
Deutschbein, Timo
author_facet Ehrlich, Kristina
Morbach, Caroline
Reiter, Theresa
Heuschmann, Peter Ulrich
Hannemann, Anke
Fassnacht, Martin
Störk, Stefan
Hahner, Stefanie
Deutschbein, Timo
author_sort Ehrlich, Kristina
collection PubMed
description BACKGROUND: Endogenous Cushing’s syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. So far, most studies focussed on distinct disease entities rather than the integrity of the CV system. We here describe the design of the Cardiovascular Status in Endogenous Cortisol Excess Study (CV-CORT-EX), a study aiming to comprehensively investigate the health status of patients with endogenous CS (with a particular focus on CV phenotypes, biochemical aspects, quality of life, and psychosocial status). METHOD: A prospective non-interventional cohort study performed at a German tertiary referral centre. At the time of enrolment, patients will be categorised as: (1) newly diagnosed overt CS, (2) recurrent overt CS, (3) CS in remission, (4) presence of mild autonomous cortisol excess (MACE). The target cohorts will be n = 40 (groups 1 + 2), n = 80 (group 3), and n = 20 (group 4). Patients with overt CS at the time of enrolment will be followed for 12 months after remission (with re-evaluations after 6 and 12 months). At each visit, patients will undergo transthoracic echocardiography, cardiac magnetic resonance imaging, 24-h electrocardiogram, 24-h blood pressure measurement, and indirect evaluation of endothelial function. Furthermore, a standardised clinical investigation, an extensive biochemical workup, and a detailed assessment of quality of life and psychosocial status will be applied. Study results (e.g. cardiac morphology and function according to transthoracic echocardiography and cardiac magnetic resonance imaging; e.g. prevalence of CV risk factors) from patients with CS will be compared with matched controls without CS derived from two German population-based studies. DISCUSSION: CV-CORT-EX is designed to provide a comprehensive overview of the health status of patients with endogenous CS, mainly focussing on CV aspects, and the holistic changes following remission. TRAIL REGISTRATION: ClinicalTrials.gov (https://clinicaltrials.gov/) NCT03880513, registration date: 19 March 2019 (retrospectively registered). Protocol Date: 28 March 2014, Version 2.
format Online
Article
Text
id pubmed-7791745
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77917452021-01-11 Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study Ehrlich, Kristina Morbach, Caroline Reiter, Theresa Heuschmann, Peter Ulrich Hannemann, Anke Fassnacht, Martin Störk, Stefan Hahner, Stefanie Deutschbein, Timo BMC Endocr Disord Study Protocol BACKGROUND: Endogenous Cushing’s syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. So far, most studies focussed on distinct disease entities rather than the integrity of the CV system. We here describe the design of the Cardiovascular Status in Endogenous Cortisol Excess Study (CV-CORT-EX), a study aiming to comprehensively investigate the health status of patients with endogenous CS (with a particular focus on CV phenotypes, biochemical aspects, quality of life, and psychosocial status). METHOD: A prospective non-interventional cohort study performed at a German tertiary referral centre. At the time of enrolment, patients will be categorised as: (1) newly diagnosed overt CS, (2) recurrent overt CS, (3) CS in remission, (4) presence of mild autonomous cortisol excess (MACE). The target cohorts will be n = 40 (groups 1 + 2), n = 80 (group 3), and n = 20 (group 4). Patients with overt CS at the time of enrolment will be followed for 12 months after remission (with re-evaluations after 6 and 12 months). At each visit, patients will undergo transthoracic echocardiography, cardiac magnetic resonance imaging, 24-h electrocardiogram, 24-h blood pressure measurement, and indirect evaluation of endothelial function. Furthermore, a standardised clinical investigation, an extensive biochemical workup, and a detailed assessment of quality of life and psychosocial status will be applied. Study results (e.g. cardiac morphology and function according to transthoracic echocardiography and cardiac magnetic resonance imaging; e.g. prevalence of CV risk factors) from patients with CS will be compared with matched controls without CS derived from two German population-based studies. DISCUSSION: CV-CORT-EX is designed to provide a comprehensive overview of the health status of patients with endogenous CS, mainly focussing on CV aspects, and the holistic changes following remission. TRAIL REGISTRATION: ClinicalTrials.gov (https://clinicaltrials.gov/) NCT03880513, registration date: 19 March 2019 (retrospectively registered). Protocol Date: 28 March 2014, Version 2. BioMed Central 2021-01-08 /pmc/articles/PMC7791745/ /pubmed/33419423 http://dx.doi.org/10.1186/s12902-020-00665-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Ehrlich, Kristina
Morbach, Caroline
Reiter, Theresa
Heuschmann, Peter Ulrich
Hannemann, Anke
Fassnacht, Martin
Störk, Stefan
Hahner, Stefanie
Deutschbein, Timo
Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title_full Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title_fullStr Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title_full_unstemmed Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title_short Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
title_sort rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (cv-cort-ex): a prospective non-interventional follow-up study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791745/
https://www.ncbi.nlm.nih.gov/pubmed/33419423
http://dx.doi.org/10.1186/s12902-020-00665-7
work_keys_str_mv AT ehrlichkristina rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT morbachcaroline rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT reitertheresa rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT heuschmannpeterulrich rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT hannemannanke rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT fassnachtmartin rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT storkstefan rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT hahnerstefanie rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy
AT deutschbeintimo rationaleanddesignofthecardiovascularstatusinpatientswithendogenouscortisolexcessstudycvcortexaprospectivenoninterventionalfollowupstudy